Literature DB >> 20697353

Id1 enhances RING1b E3 ubiquitin ligase activity through the Mel-18/Bmi-1 polycomb group complex.

T Qian1, J-Y Lee, J-H Park, H-J Kim, G Kong.   

Abstract

The helix-loop-helix inhibitor of differentiation and DNA binding (Id1) is well known as an oncogene in various tumors. Although it has been reported that Id1 promotes several oncogenic processes, it is still unclear whether Id1 functions through epigenetic transcriptional regulation. In this study, we examined the effect of Id1 on polycomb group (PcG) proteins, which are crucial epigenetic gene silencers, and found that Id1 regulated the expression of Mel-18 and Bmi-1, both of which belong to polycomb repressive complex 1. We also confirmed that Id1 induced Mel-18 downregulation, which was mediated by the Akt pathway, and consequently upregulated the transcription of its target gene, c-Myc. Using a promoter-reporter, we demonstrated that Id1 regulated Bmi-1 transcription through c-Myc binding to its E-box in the promoter. Finally, we examined the activity of E3 ligase RING1b, whose catalytic activity is increased by binding with the RING finger protein Bmi-1, and found that Id1 overexpression enhanced RING1b E3 ligase activity leading to accumulation of H2A ubiquitination and ubiquitin/proteasome-mediated degradation of geminin. Taken together, our study provided a novel link between Id1 and PcG proteins and suggested that Id1 may contribute to tumor development through PcG-mediated epigenetic regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697353     DOI: 10.1038/onc.2010.317

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

Review 1.  Functional conservation and divergence of J-domain-containing ZUO1/ZRF orthologs throughout evolution.

Authors:  Dong-Hong Chen; Yong Huang; Chunlin Liu; Ying Ruan; Wen-Hui Shen
Journal:  Planta       Date:  2014-06       Impact factor: 4.116

2.  MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.

Authors:  Jeong-Yeon Lee; Hee-Young Won; Ji-Hye Park; Hye-Yeon Kim; Hee-Joo Choi; Dong-Hui Shin; Ju-Hee Kang; Jong-Kyu Woo; Seung-Hyun Oh; Taekwon Son; Jin-Woo Choi; Sehwan Kim; Hyung-Yong Kim; Kijong Yi; Ki-Seok Jang; Young-Ha Oh; Gu Kong
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

Review 3.  Context-dependent actions of Polycomb repressors in cancer.

Authors:  M Koppens; M van Lohuizen
Journal:  Oncogene       Date:  2015-06-08       Impact factor: 9.867

4.  Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression.

Authors:  Maya Zigler; Gabriel J Villares; Andrey S Dobroff; Hua Wang; Li Huang; Russell R Braeuer; Takafumi Kamiya; Vladislava O Melnikova; Renduo Song; Ran Friedman; Rhoda M Alani; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2011-04-05       Impact factor: 12.701

Review 5.  Polycomb group proteins and MYC: the cancer connection.

Authors:  Leonidas Benetatos; George Vartholomatos; Eleftheria Hatzimichael
Journal:  Cell Mol Life Sci       Date:  2013-07-30       Impact factor: 9.261

6.  Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis.

Authors:  Dong-Hui Shin; Ji-Hye Park; Jeong-Yeon Lee; Hee-Young Won; Ki-Seok Jang; Kyueng-Whan Min; Si-Hyong Jang; Jong-Kyu Woo; Seung Hyun Oh; Gu Kong
Journal:  Oncotarget       Date:  2015-07-10

Review 7.  Regulation of gene transcription of B lymphoma Mo-MLV insertion region 1 homolog (Review).

Authors:  Meizhen Zhou; Qichao Xu; Deqiang Huang; Lingyu Luo
Journal:  Biomed Rep       Date:  2021-04-05

Review 8.  Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer.

Authors:  Guan-Jun Dong; Jia-Le Xu; Yu-Ruo Qi; Zi-Qiao Yuan; Wen Zhao
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.